Related Experiment Video
Updated: Jun 17, 2025
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Platelet transfusion enhances pro-aggregatory status shortly after coronary artery bypass grafting (CABG while
Javad Ahmadi1,2, Ehteramolsadat Hosseini1, Faranak Kargar3
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Insights
Platelet transfusions in coronary artery bypass grafting (CABG) patients significantly impact platelet function, increasing inflammatory markers immediately and pro-aggregatory markers later. These effects may be modulated by transforming growth factor-beta-1 (TGF-β1).
Area of Science:
- Cardiovascular Surgery
- Hematology
- Immunology
Background:
- Coronary artery bypass grafting (CABG) surgery induces inflammation, potentially impairing platelet function and necessitating transfusions.
- Stored platelets are a source of biological mediators that can influence post-operative inflammatory and immune responses.
Purpose of the Study:
- To investigate the effects of platelet transfusion on pro-aggregatory, pro-inflammatory, and immunomodulatory markers in CABG patients.
- To analyze the temporal changes in platelet activation and mediator expression following transfusion during CABG.
Main Methods:
- Flow cytometry was used to measure P-selectin, CD40 ligand (CD40L), and PAC-1 binding on platelets from 20 CABG patients (10 transfused, 10 not).
- Intra-platelet transforming growth factor-beta-1 (TGF-β1) was analyzed via western blotting.
- Measurements were taken at five time points: 24 hours pre-surgery, immediately, 2 hours, 24 hours, and 1 week post-surgery.
Main Results:
- Transfused patients showed increased P-selectin, CD40L, and TGF-β1 levels 2 hours post-surgery compared to non-transfused patients (p < 0.05).
- PAC-1 binding was elevated 24 hours post-surgery in transfused patients (p < 0.05).
- A week after surgery, transfused patients exhibited reduced pro-inflammatory platelet markers, potentially linked to TGF-β1's immunomodulatory effects.
Conclusions:
- Platelet transfusion significantly alters the pro-inflammatory, pro-aggregatory, and immunomodulatory state of platelets in CABG patients.
- These effects manifest with immediate (pro-inflammatory), midterm (pro-aggregatory), and delayed (attenuated inflammation) consequences.
- The immunomodulatory role of TGF-β1 may contribute to the observed late reduction in platelet pro-inflammatory markers post-transfusion.
Abstract:
During coronary artery bypass grafting (CABG), the surgical procedure, particularly the manipulation of the major arteries of the heart, induces a significant inflammatory state that may compromise platelet function to the extent that platelet transfusion is required. Given stored platelets as a major source of biological mediators, this study investigates the effects of platelet transfusion on the major pro-aggregatory, pro-inflammatory and immunomodulatory markers of platelets. Platelets from 20 patients, 10 who received platelet transfusion and 10 without, were subjected to flow cytometery where P-selectin and CD40 ligand (CD40L) expressions and PAC-1 binding (activation-specific anti GPIIb/GPIIIa antibody) analysed at five-time points of 24 h before surgery, immediately, 2 h, 24 h and 1 week after surgery. Analysis of intra-platelet transforming growth factor-beta-1 (TGF-β1) was also conducted using western blotting. Patients with platelet transfusion showed increased levels of P-selectin, CD40L and intra-platelet TGF-β1 2-h after surgery compared to those without transfusion (p < 0.05). PAC-1 binding was increased 24 h after surgery in transfused patients (p < 0.05). Given the significant post-transfusion elevation of platelet TGF-β1, P-sel/CD40L reduction in transfused patients a week after was of much interest. This study showed for the first time the significant effects of platelet transfusion on the pro-inflammatory, pro-aggeregatory and immunomodulatory state of platelets in CABG patients, which manifested with immediate, midterm and delayed consequences. While the increased pro-inflammatory conditions manifested as an immediate effect of platelet transfusion, the pro-aggregatory circumstances emerged 24 h post-transfusion. A week after surgery, attenuations of pro-inflammatory markers of platelets in transfused patients were shown, which might be due to the immunomodulatory effects of TGF-β1.
More Related Videos
Related Concept Videos
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:16Clot Retraction and Fibrinolysis
01:05Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...